ACORDA THERAPEUTICS INC
ACORDA THERAPEUTICS INC (ACOR) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 1000 transactions totaling $186.5M, demonstrating a bearish sentiment with -$156.3M in net insider flow. The most recent transaction on Mar 17, 2023 involved a purchase of 10,000 shares valued at $6.5K.
ACOR Insider Activity Summary
Who Is Buying ACOR Stock?
No significant insider buying has been recorded for ACOR in the recent period.
Who Is Selling ACOR Stock?
No significant insider selling has been recorded for ACOR in the recent period.
Is ACORDA THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACOR is bearish with an Insider Alignment Score of 8/100 and a net flow of -$156.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ACOR Frequently Asked Questions
Understanding ACOR Insider Activity
Insider trading at ACORDA THERAPEUTICS INC (ACOR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading ACOR stock, having executed 1000 transactions in the past 90 days. The most active insider is Management, Inc. Scopia (Executive), who has made 17 transactions totaling $38.2M.
Related Tools
Track ACORDA THERAPEUTICS INC Insider Activity
Get notified when executives and directors at ACOR file new Form 4 transactions